Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

OTX008

😃Good
Catalog No. T16413Cas No. 286936-40-1
Alias PTX008, Calixarene 0118

OTX008 (PTX008) is a selective galectin-1 inhibitor.

OTX008

OTX008

😃Good
Purity: 99.84%
Catalog No. T16413Alias PTX008, Calixarene 0118Cas No. 286936-40-1
OTX008 (PTX008) is a selective galectin-1 inhibitor.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$64In StockIn Stock
5 mg$155In StockIn Stock
10 mg$237In StockIn Stock
25 mg$488In StockIn Stock
50 mg$698In StockIn Stock
100 mg$968In StockIn Stock
500 mg$1,930-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.84%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
OTX008 (PTX008) is a selective galectin-1 inhibitor.
In vitro
OTX008 inhibits Gal1 expression and ERK1/2 and AKT-dependent survival pathways in SQ20B and A2780-1A9 cells and induces G2/M cell cycle arrest through CDK1. OTX008 increases the anti-proliferative effects of Semaphorin-3A (Sema3A) in SQ20B cells and reverses invasion induced by exogenous Gal1. Growth inhibitory concentrations (GI50) of OTX008 range from 3 to 500 μM in a large panel of human solid tumor cell lines. A significant correlation between OTX008 GI50 values and Gal1 mRNA (LGALS1) and protein expression levels in the panel of cancer cells is observed. OTX008 affects endothelial cell proliferation, motility, invasiveness, and cord formation. Tumor cell proliferation is also inhibited, with differences in sensitivity among cell lines (IC50 from 1 to 190 μM)[1][2].
In vivo
OTX008 treatment is associated with the down-regulation of Gal1 and Ki67 in treated tumors, as well as decreased microvessel density and VEGFR2 expression. OTX008 inhibits the growth of A2780-1A9 xenografts. Combination studies display OTX008 synergy with several cytotoxic and targeted therapies, principally when OTX008 is administered first[1].
SynonymsPTX008, Calixarene 0118
Chemical Properties
Molecular Weight937.18
FormulaC52H72N8O8
Cas No.286936-40-1
SmilesO(CC(NCCN(C)C)=O)C=1C=2CC=3C(OCC(NCCN(C)C)=O)=C(CC=4C(OCC(NCCN(C)C)=O)=C(CC5=C(OCC(NCCN(C)C)=O)C(CC1C=CC2)=CC=C5)C=CC4)C=CC3
Relative Density.1.155 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 1 mg/mL (1.07 mM), Sonication is recommended.
Ethanol: 33.33 mg/mL (35.56 mM), Sonication is recommended.
Solution Preparation Table
DMSO/Ethanol
1mg5mg10mg50mg
1 mM1.0670 mL5.3352 mL10.6703 mL53.3515 mL
Ethanol
1mg5mg10mg50mg
5 mM0.2134 mL1.0670 mL2.1341 mL10.6703 mL
10 mM0.1067 mL0.5335 mL1.0670 mL5.3352 mL
20 mM0.0534 mL0.2668 mL0.5335 mL2.6676 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy OTX008 | purchase OTX008 | OTX008 cost | order OTX008 | OTX008 chemical structure | OTX008 in vivo | OTX008 in vitro | OTX008 formula | OTX008 molecular weight